OVERVIEW: The Dystonia Medical Research Foundation backs research into the causes, diagnosis, prevention and treatment of movement disorders.
IP TAKE: This is a pretty approachable funder, especially for young researchers just getting their careers underway. While investigators won’t find a ton of money here, backing from this foundation is a good start to getting feet in the door with other funders.
PROFILE: The Dystonia Medical Research Foundation (DMRF) was founded in 1976 by Samuel and Frances Belzberg. As the name of the foundation indicates, it is dedicated to funding “research related to the causes, mechanisms, prevention, and treatment of all dystonias.” DMRF's mission is to advance research for treatments and a cure, and also to promote awareness of the multiple forms of dystonia and movement disorders.
The foundation currently has two main funding programs. The Mahlon DeLong Young Investigator Award offers a $50,000 grant for salary support and $5,000 for related research project costs to investigators who have a doctoral degree and are within five years of completing their Ph.D. training, medical residency or equivalent. The application deadline or this award is around the middle of October each year.
DMRF's Basic and Clinical Aspects of Dystonia program provides support of up to two years with a $65,000 maximum budget. Grants are awarded to projects that address the “most significant and immediate needs” of dystonia research. The submission deadline for letters of intent are also around the middle of October each year.
To get an idea of what sort of research DMRF supports, have a look at their list of current projects.
DMRF also operates a Clinical Fellowship Training program, sponsoring one-year, $75,000 clinical fellowships for second-year physician fellows. The focus of the fellowship is diagnosis and treatment of movement disorders with an emphasis on dystonia. The fellowships are made in partnership with Merz Pharmaceuticals and the Allergan Foundation.
- Janet Heishetter, Executive Director
- Jan Teller, Chief Scientific Officer